AJX-27587-39834
4 vaccinations
1 coded response
44 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 605 / IL
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-22
Registered in v-safe
-
2021-01-22
Dose 1 — Moderna
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-02-05
- 2021-02-12
-
2021-02-19
Dose 2 — Moderna
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-21
- 2021-08-21
-
2021-10-31
Dose 3 — ModernaCo-administered: Flu
- 2021-10-31
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-03
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-14
- 2021-11-21
- 2021-11-28
- 2021-12-05
-
2022-01-30
Survey response — 3 months, dose 3MedDRA: Anosmia, Oropharyngeal pain, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Fever, sore throat, loss of smell, and runny nose.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-01
-
2022-09-23
Dose 4 — ModernaCo-administered: Flu
-
2022-09-25
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Chills, Fatigue or tirednessAdult check-in
- 2022-09-26
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-23
- 2022-11-03
- 2022-11-04
- 2022-12-25
- 2023-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Moderna | |
| 2 | 2021-02-19 | Moderna | |
| 3 | 2021-10-31 | Moderna | Flu |
| 4 | 2022-09-23 | Moderna | Flu |
Free text
Release 11 — 3 months, dose 3
Symptoms: Fever, sore throat, loss of smell, and runny nose.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release